Research Article
Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
| Characteristics | Total (%) or median (range) |
| Gender () | | Male | 25 (75.8) | Female | 8 (24.2) | Age (years) | 55 (42–75) | Reason for uncontrolled disease () | | Recurrent | 12 (36.4) | Residual | 21 (63.6) | AFP before CyberKnife (ng/mL) | | >400 | 5 (15.2) | >200, <400 | 8 (24.2) | >50, <200 | 13 (39.4) | >4, <50 | 7 (21.2) | Clinical staging () | | I | 4 (12.1) | II | 15 (45.5) | III | 14 (42.4) |
|
|
According to 2010 AJCC staging system. |